Health
Vaccine experts meeting over clot report – Hepburn Advocate
A Melbourne man’s rare blood clotting disorder, likely linked to the AstraZeneca COVID-19 vaccine, will not affect its rollout to Australians. The Therapeutic……
A Melbourne man’s rare blood clotting disorder, likely linked to the AstraZeneca COVID-19 vaccine, will not affect its rollout to Australians.
The Therapeutic Goods Administration and Australian Technical Advisory Group on Immunisation met on Saturday morning and Acting Chief Medical Officer Michael Kidd said no changes to the AstraZeneca rollout were recommended.
He said it was likely, given similarities with rare overseas cases, that the man’s clotting disorder was related to him receiving the…
-
General15 hours agoChina and Philippines trade blame over latest South China Sea clash
-
General16 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire
-
General15 hours agoOf saints and sinners | The Spectator Australia
-
Noosa News20 hours agoBrisbane rising on global rankings, but still behind southern capitals